RE:RE:RE:RE:TimeframeTaking advantage of market sentiment and momentum does make sense. I am just worried that there might be some investors that will unwittingly become too hyped on the NRs, not see it translate in the Q3 numbers (which it shouldn't), become a little bit dejected and dump their stock, leading to a slow in momentum and drop in share price.
Again, it's just my brain thinking, and being new to stocks and investments, I do not know how they work. So am 100% making assumptions.
I will say, regardless of whether the stock price hits $5 or not, I actually like what this company is doing for the benefit of the world, and hope that it can expand to include testing and identification of other diseases.